v3.26.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Research and development costs, net $ 652 $ 319
General and administrative costs 1,245 458
Total operating expenses 1,897 777
Operating loss (1,897) (777)
Other income (Note 3d) 1,287
Financial income (expenses), net 49 (29)
Equity in losses from investment in affiliate (42) (36)
Loss before income tax (603) (842)
Tax income 70
Net loss (533) (842)
Net loss attributable to non-controlling interest (146)
Net loss attributable to the Company (387) (842)
Other comprehensive loss (263) (3)
Total comprehensive loss (796) (845)
Comprehensive loss attributable to non-controlling interests (153)
Comprehensive loss attributable to the Company $ (643) $ (845)
Basic loss per common stock $ (0.04) $ (0.09)
Diluted loss per common stock $ (0.04) $ (0.09)
Weighted average common stock outstanding 10,509,347 9,157,398